CAPR - CAPRICOR THERAPEUTICS, INC.
IEX Last Trade
12.72
0.220 1.730%
Share volume: 745,175
Last Updated: Mon 13 Jan 2025 10:00:00 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.38%
PREVIOUS CLOSE
CHG
CHG%
$12.50
-0.47
-0.04%
View ratios
| Fiscal Date | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 2024-05-14 | 2023-08-08 | 2023-11-14 | 2024-11-14 | 2024-05-14 | 2024-08-08 | 2024-11-14 | |
| Cash flow financing | 3.895 K | 2.188 M | 221.081 K | 23.167 M | 2.290 M | 2.067 M | 67.327 M | |
| Other financing cash flows | 3.895 K | 57.679 K | 0.000 | 3.027 K | 0.000 | 81.222 K | 120.995 K | |
| Cash flow | 1.002 M | -768.395 K | -852.466 K | 5.710 M | -8.480 M | 4.474 M | 57.689 M | |
| Net income | -7.768 M | -7.367 M | -6.391 M | -762.089 K | -9.794 M | -11.000 M | -12.557 M | |
| Depreciation | 230.101 K | 254.702 K | 276.471 K | 307.608 K | 331.406 K | 356.935 K | 361.168 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -3.212 M | 6.461 M | 7.721 M | -5.863 M | -9.502 M | 14.695 M | 2.005 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | -105.425 K | -97.570 K | -362.260 K | -170.618 K | -55.729 K | -20.566 K | -49.885 K | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 347.690 K | 135.873 K | 269.493 K | 558.604 K | 608.588 K | 60.340 K | 9.145 K | |
| Cash Change | 1.002 M | -768.395 K | -852.466 K | 5.710 M | -8.480 M | 4.474 M | 57.689 M |